Association of paraoxonase polymorphisms with carotid artery atherosclerosis in essential hypertension patients

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 5174-5185

  Han, L ^a   Xu, X J ^a   Liang, X H ^a   Ma, J ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Carotid artery atherosclerotic disease; Essential hypertension; Gene polymorphism; Paraoxonase (PON)

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; DNA; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN; PON2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CHINA; CHINESE; CONTROLLED STUDY; DNA ISOLATION; ECHOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PON1 GENE; PON2 GENE; RESTRICTION MAPPING; RISK FACTOR; ALLELE; AMINO ACID SUBSTITUTION; ATHEROSCLEROSIS; CAROTID ARTERY; CASE CONTROL STUDY; COMPLICATION; ETHNIC GROUP; GENETICS; HYPERTENSION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ALLELES; AMINO ACID SUBSTITUTION; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHINA; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84887333573     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.October.30.2     Document Type: Article

References (38)

1. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, et al. (1998). Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101: 1581-1590.
2. Chen Q, Reis SE, Kammerer CM, McNamara DM, et al. (2003). Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Am. J. Hum. Genet. 72: 13-22.
3. Durrington PN, Mackness B and Mackness MI (2001). Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21: 473-480.
4. Harangi M, Seres I, Magyar MT, Csipo I, et al. (2008). Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease. Cerebrovasc. Dis. 25: 122-128.
5. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, et al. (1997). Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82: 3373-3377.
6. Hegele RA, Harris SB, Connelly PW, Hanley AJ, et al. (1998). Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree. Clin. Genet. 54: 394-399.
7. Hong SH, Song J, Min WK and Kim JQ (2001). Genetic variations of the paraoxonase gene in patients with coronary artery disease. Clin. Biochem. 34: 475-481.
8. Imai Y, Morita H, Kurihara H, Sugiyama T, et al. (2000). Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149: 435-442.
9. Jander S, Sitzer M, Wendt A, Schroeter M, et al. (2001). Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization. Stroke 32: 850-854.
10. Jin YZ and Wang BN (2010). Clinical analysis on correlation risk factors of carotid arteries scleratheroma. Anhui Med. J. 31: 556-559.
11. Kao Y, Donaghue KC, Chan A, Bennetts BH, et al. (2002). Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes. Diabet. Med. 19: 212-215.
12. Leus FR, Zwart M, Kastelein JJ and Voorbij HA (2001). PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients. Atherosclerosis 154: 641-649.
13. Leviev I and James RW (2000). Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler. Thromb. Vasc. Biol. 20: 516-521.
14. Mackness B, Davies GK, Turkie W, Lee E, et al. (2001). Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler. Thromb. Vasc. Biol. 21: 1451-1457.
15. Mackness MI, Arrol S, Abbott C and Durrington PN (1993). Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104: 129-135.
16. Mackness MI, Mackness B, Durrington PN, Fogelman AM, et al. (1998). Paraoxonase and coronary heart disease. Curr. Opin. Lipidol. 9: 319-324.
17. Malin R, Jarvinen O, Sisto T, Koivula T, et al. (2001a). Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis. Atherosclerosis 157: 301-307.
18. Malin R, Loimaala A, Nenonen A, Mercuri M, et al. (2001b). Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men. Metabolism 50: 1095-1101.
19. Martinelli N, Girelli D, Olivieri O, Stranieri C, et al. (2004). Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction. Eur. J. Clin. Invest. 34: 14-20.
20. Mathiesen EB, Bonaa KH and Joakimsen O (2001). Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromso study. Circulation 103: 2171-2175.
21. Mochizuki H, Scherer SW, Xi T, Nickle DC, et al. (1998). Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene 213: 149-157.
22. Nagai Y, Kitagawa K, Sakaguchi M, Shimizu Y, et al. (2001). Significance of earlier carotid atherosclerosis for stroke subtypes. Stroke 32: 1780-1785.
23. Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, et al. (2001). Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 276: 44444-44449.
24. Ng CJ, Shih DM, Hama SY, Villa N, et al. (2005). The paraoxonase gene family and atherosclerosis. Free Radic. Biol. Med. 38: 153-163.
25. Primo-Parmo SL, Sorenson RC, Teiber J and La Du BN (1996). The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33: 498-507.
26. Roest M, Rodenburg J, Wiegman A, Kastelein JJ, et al. (2006). Paraoxonase genotype and carotid intima-media thickness in children with familial hypercholesterolemia. Eur. J. Cardiovasc. Prev. Rehabil. 13: 464-466.
27. Rontu R, Karhunen PJ, Ilveskoski E, Mikkelsson J, et al. (2003). Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: an autopsy study. Atherosclerosis 171: 31-37.
28. Rontu R, Lehtimaki T, Ilveskoski E, Mikkelsson J, et al. (2004). Association of paraoxonase-1 M55L genotype and alcohol consumption with coronary atherosclerosis: the Helsinki Sudden Death Study. Pharmacogenetics 14: 479-485.
29. Sanghera DK, Aston CE, Saha N and Kamboh MI (1998). DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am. J. Hum. Genet. 62: 36-44.
30. Schmidt H, Schmidt R, Niederkorn K, Gradert A, et al. (1998). Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 29: 2043-2048.
31. Shi LH, Woodward DJ, Luo F, Anstrom K, et al. (2004). High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions. Brain Res. 1013: 98-106.
32. Wang XY, Xue YM, Zhang NL, Ji Z, et al. (2004). Paraoxonase 2 gene C311S polymorphism observed of Han nationality in Guangdong region. Guangdong Med. J. 25: 24-25.
33. Watson AD, Berliner JA, Hama SY, La Du BN, et al. (1995). Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96: 2882-2891.
34. Yamada Y, Ando F, Niino N, Miki T, et al. (2003). Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese. J. Hum. Genet. 48: 469-475.
35. Yang HP, Zhao WJ, Shen YF and et al (2006). Association of PON2 311 and β-fibrinogen-455 gene polymorphism with atherothrombotic cerebral infarction. Clin. Med. Chin. 22: 217-220.
36. Yen Y, Lim DW, Chung V, Morgan RJ, et al. (2008). Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial. Am. J. Clin. Oncol. 31: 317-322.
37. Zhao H and Ding SJ (2005). Genetic Research in Carotid Atherosclerosi. Cerebrovasc. Dis. Foreign Med. Sci. 13: 232-235.
38. Zou YQ and Ge XH (1999). Experienced Handbook of Ultrasonic Doppler for Cervica Artery. Xueyuan Chubanshe, Beijing.